These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19441125)

  • 1. Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature.
    Anderka MT; Lin AE; Abuelo DN; Mitchell AA; Rasmussen SA
    Am J Med Genet A; 2009 Jun; 149A(6):1241-8. PubMed ID: 19441125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In utero exposure to mycophenolate mofetil: a characteristic phenotype?
    Perez-Aytes A; Ledo A; Boso V; Sáenz P; Roma E; Poveda JL; Vento M
    Am J Med Genet A; 2008 Jan; 146A(1):1-7. PubMed ID: 18074358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil embryopathy may be dose and timing dependent.
    Ang GS; Simpson SA; Reddy AR
    Am J Med Genet A; 2008 Aug; 146A(15):1963-6. PubMed ID: 18570296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital diaphragmatic hernia and microtia in a newborn with mycophenolate mofetil (MMF) exposure: phenocopy for Fryns syndrome or broad spectrum of teratogenic effects?
    Parisi MA; Zayed H; Slavotinek AM; Rutledge JC
    Am J Med Genet A; 2009 Jun; 149A(6):1237-40. PubMed ID: 19449404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrada of the possible mycophenolate mofetil embryopathy: a review.
    Merlob P; Stahl B; Klinger G
    Reprod Toxicol; 2009 Jul; 28(1):105-8. PubMed ID: 19491002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrauterine exposure to mycophenolate mofetil and multiple congenital anomalies in a newborn: possible teratogenic effect.
    Jackson P; Paquette L; Watiker V; Randolph L; Ramanathan R; Seri I
    Am J Med Genet A; 2009 Jun; 149A(6):1231-6. PubMed ID: 19334090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal exposure to mycophenolate mofetil: an updated estimate.
    Klieger-Grossmann C; Chitayat D; Lavign S; Kao K; Garcia-Bournissen F; Quinn D; Luo V; Sermer M; Riordan S; Laskin C; Matok I; Gorodischer R; Chambers C; Levi A; Koren G
    J Obstet Gynaecol Can; 2010 Aug; 32(8):794-7. PubMed ID: 21050513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil embryopathy: A newly recognized teratogenic syndrome.
    Perez-Aytes A; Marin-Reina P; Boso V; Ledo A; Carey JC; Vento M
    Eur J Med Genet; 2017 Jan; 60(1):16-21. PubMed ID: 27639443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential teratogenic effects of allopurinol: a case report.
    Kozenko M; Grynspan D; Oluyomi-Obi T; Sitar D; Elliott AM; Chodirker BN
    Am J Med Genet A; 2011 Sep; 155A(9):2247-52. PubMed ID: 21815259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of mycophenolate mofetil in pregnancy.
    Pisoni CN; D'Cruz DP
    Expert Opin Drug Saf; 2008 May; 7(3):219-22. PubMed ID: 18462179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil: emerging as a potential human teratogen.
    Koren G
    Can Fam Physician; 2008 Aug; 54(8):1112-3. PubMed ID: 18697969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus.
    Sifontis NM; Coscia LA; Constantinescu S; Lavelanet AF; Moritz MJ; Armenti VT
    Transplantation; 2006 Dec; 82(12):1698-702. PubMed ID: 17198262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe facial clefts in acrofacial dysostosis: a consequence of prenatal exposure to mycophenolate mofetil?
    Schoner K; Steinhard J; Figiel J; Rehder H
    Obstet Gynecol; 2008 Feb; 111(2 Pt 2):483-6. PubMed ID: 18238994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital Esophageal Atresia and Microtia in a Newborn Secondary to Mycophenolate Mofetil Exposure During Pregnancy: A Case Report and Review of the Literature.
    Alsebayel MM; Abaalkhail FA; Alsebayel FM; Alissa DA; Al-Jedai AH; Elsiesy H
    Am J Case Rep; 2018 May; 19():523-526. PubMed ID: 29720579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation.
    Dei Malatesta MF; Rocca B; Gentile T; Hadjistilianou T; Borri M; de Francesco S; Pisani F; Famulari A
    Transplant Proc; 2009 May; 41(4):1407-9. PubMed ID: 19460573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal atresia and prenatal exposure to mycophenolate.
    Martín MC; Cristiano E; Villanueva M; Bonora ML; Berguio N; Tocci A; Groisman B; Bidondo MP; Liascovich R; Barbero P
    Reprod Toxicol; 2014 Dec; 50():117-21. PubMed ID: 25461910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonographic diagnosis of fetal malformations associated with mycophenolate mofetil exposure in utero.
    Huang SY; Chueh HY; Shaw SW; Shih JC; Cheng PJ
    Am J Obstet Gynecol; 2008 Aug; 199(2):e6-8. PubMed ID: 18486091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations.
    Le Ray C; Coulomb A; Elefant E; Frydman R; Audibert F
    Obstet Gynecol; 2004 May; 103(5 Pt 2):1091-4. PubMed ID: 15121619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An additional patient with mycophenolate mofetil embryopathy: cardiac and facial analyses.
    Lin AE; Singh KE; Strauss A; Nguyen S; Rawson K; Kimonis VE
    Am J Med Genet A; 2011 Apr; 155A(4):748-56. PubMed ID: 21594997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal proximal and distal limb anomalies following exposure to mycophenolate mofetil during pregnancy: A case report and review of the literature.
    Abdulaziz HM; Shemies RS; Taman M; Mosbah A; Elkannishy G
    Lupus; 2021 Aug; 30(9):1522-1525. PubMed ID: 34082587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.